Exelixis, Inc. (EXEL)
NASDAQ·Healthcare·Biotechnology
$53.12
-0.70%
Mkt Cap $13.01B
Analyst Ratings
Buy
6
Hold
9
Sell
0
Price Target (53 analysts)
$44.11
Range $30.00 – $54.00
Implied Upside
-17.0%
Consensus $44.11 vs current $53.12
NASDAQ·Healthcare·Biotechnology
$53.12
-0.70%
Mkt Cap $13.01B
Buy
6
Hold
9
Sell
0
Price Target (53 analysts)
$44.11
Range $30.00 – $54.00
-17.0%
Consensus $44.11 vs current $53.12